Q4 2022 Holdings
Filed 2023-02-14 | 40 holdings | $853.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $70.9M | 3,900,000 | 8.3% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $69.8M | 1,350,000 | 8.2% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $68.7M | 1,500,000 | 8.1% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $55.9M | 3,150,000 | 6.6% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $44.5M | 5,286,666 | 5.2% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $42.5M | 1,435,000 | 5.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $35.5M | 900,000 | 4.2% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $32.1M | 1,500,000 | 3.8% |
| Karuna Therapeutics Inc | COM | 48576A100 | $29.5M | 150,000 | 3.5% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $29.2M | 1,000,000 | 3.4% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $28.7M | 2,797,501 | 3.4% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $28.5M | 500,000 | 3.3% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $28.5M | 220,000 | 3.3% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $26.5M | 2,349,600 | 3.1% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $24.9M | 2,150,000 | 2.9% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $21.9M | 400,000 | 2.6% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $21.5M | 657,016 | 2.5% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $20.7M | 1,400,000 | 2.4% |
| Dice Therapeutics Inc | COM | 23345J104 | $20.6M | 660,000 | 2.4% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $17.4M | 60,000 | 2.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $14.7M | 750,000 | 1.7% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $14.6M | 2,000,000 | 1.7% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $12.9M | 864,960 | 1.5% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $12.7M | 1,100,000 | 1.5% |
| Geron Corp(GERN) | COM | 374163103 | $9.7M | 4,000,000 | 1.1% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $9.2M | 3,743,875 | 1.1% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $8.4M | 525,000 | 1.0% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $8.2M | 260,000 | 1.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $7.8M | 1,250,000 | 0.9% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $7.7M | 250,000 | 0.9% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $6.8M | 180,000 | 0.8% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $5.5M | 285,000 | 0.6% |
| Prometheus Biosciences Inc | COM | 74349U108 | $5.5M | 50,000 | 0.6% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $4.0M | 200,000 | 0.5% |
| Morphosys AG | SPONSORED ADS | 617760202 | $3.2M | 900,000 | 0.4% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $2.4M | 188,390 | 0.3% |
| Spruce Biosciences Inc | COM | 85209E109 | $1.1M | 1,000,000 | 0.1% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $842.5K | 110,856 | 0.1% |
| Lianbio | SPONSORED ADS | 53000N108 | $459.2K | 280,000 | 0.1% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 07/07/202 | 67080N119 | $9.6K | 66,666 | 0.0% |